Emergent BioSolutions (EBS) has secured a $51.9M contract modification award to deliver CNJ-016 to the Administration for Strategic Preparedness and Response (A ...

About an hour after the closing bell, shares of Emergent were trading 6.4% higher, at $7.31. The company's shares ended the day's regular session at $6.87, a gain of 3.7%.

Emergent BioSolutions Inc. (NYSE: EBS) today announced a contract modification has been secured to deliver CNJ-016® [Vaccinia Immune Globulin Intravenous (Human)] (VIGIV) to the Administration for ...

Investing.com -- Emergent BioSolutions Inc (NYSE: EBS) stock rose 6.3% after the company announced a contract modification to deliver additional doses of its smallpox vaccination complication ...

A coalition of doctors’ groups and public health organizations sued the U.S. government on Monday over the decision to stop ...

In April of that year, patients started appearing at hospitals in the industrial city of Sverdlovsk, now known as ...

The 19th-century power struggle between the Sikhs, the British, and the Afghans shaped the political landscape of the time.

A music project has been released based on the Manx family history writings of a 93 year old. George Callow’s parents were ...

A coalition of doctors' groups and public health organizations sued the US government on Monday over what they are calling ...